Your browser doesn't support javascript.
loading
Trigeminal Zoster with drug-induced labial angioedema leading to necrosis.
Coyle, David Tyler.
Affiliation
  • Coyle DT; University of Colorado School of Medicine, Department of Psychiatry, Aurora, CO 80045, USA.
Med Pharm Rep ; 95(4): 467-470, 2022 Oct.
Article in En | MEDLINE | ID: mdl-36506612
ABSTRACT

Introduction:

Zoster is caused by the reactivation of a dormant viral infection, and is characterized by painful, vesicular lesions along a dermatome. Neuritic pain associated with zoster can be treated with anticonvulsant medications. Case Report An immunocompetent adult physician developed prominent zoster lesions in the trigeminal nerve distribution. Treatment included antiviral therapy for the acute infection, and pharmacotherapy for neuritic pain. Pharmacotherapy included several anticonvulsant agents, with labial angioedema developing after initiation of oxcarbazepine.

Discussion:

The case is notable for the pictorial timeline of lesion development, as well as the marked incident angioedema following initiation of treatment for neuritis with oxcarbazepine.

Conclusions:

Clinicians should remain vigilant for drug-induced facial angioedema when treating patients with trigeminal zoster-related neuritis due to the potential for angioedema to aggravate a lesion, resulting in scarring. Angioedema of the head and neck should be closely monitored due to the potential for airway compromise.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Med Pharm Rep Year: 2022 Document type: Article Affiliation country: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Med Pharm Rep Year: 2022 Document type: Article Affiliation country: Estados Unidos